Benefits of Organized Mammographic Screening Programs in Women Aged 50 to 69 years: A Surgical Perspective

Clin Breast Cancer. 2019 Oct;19(5):e637-e642. doi: 10.1016/j.clbc.2019.04.013. Epub 2019 May 2.

Abstract

Background: The benefits of organized mammographic screening programs (OMSPs) in reducing breast cancer mortality have been addressed by several studies. This study was designed to specifically evaluate the advantages of OMPSs in terms of surgical management of patients with breast cancer.

Materials and methods: Surgical treatment of 201 patients with breast cancer aged 50 to 69 years coming from OMSPs was compared with that of 532 non-OMSP patients in same age group. The likelihood of receiving BCS was analyzed through a multivariable regression model.

Results: The mean tumor size was smaller in the OMSP patients (14 mm vs. 18 mm; P < .01). The proportion of patients having metastatic lymph nodes was higher in the non-OMSP group (33.3% vs. 17.9%; P < .01). Rates of breast-conserving surgery (BCS) were significantly higher in the OMSP group (89.1% vs. 59.1%; P < .01). Sentinel node biopsy was carried out in 84.1% and 62.5% of patients in the OMSP and non-OMSP groups, respectively (P < .01). Rates of axillary lymph node dissection were significantly different (24.9% in the OMSP group and 35.8% in the non-OMSP group; P = .02). Re-excisions for infiltrated margins after BCS were lower in the OMSP group (4.8% vs. 12.7%; P < .01). Hospital stay was shorter in the OMSP group (2.13 vs. 3.02 days; P < .01). OMPS women had a 3-fold higher probability of receiving BCS.

Conclusions: Patients with breast cancer belonging to OMSPs had a higher probability to receive less invasive surgery and to have shorter hospital stay. Our results support the use of campaigns aimed at increasing adhesion to mammography screening.

Keywords: Breast-conserving surgery; Mammography; Screening; Sentinel node biopsy; Surgery.

MeSH terms

  • Aged
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / surgery*
  • Carcinoma, Ductal, Breast / diagnosis
  • Carcinoma, Ductal, Breast / surgery*
  • Carcinoma, Intraductal, Noninfiltrating / diagnosis
  • Carcinoma, Intraductal, Noninfiltrating / surgery*
  • Early Detection of Cancer / statistics & numerical data*
  • Female
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision / methods*
  • Mammography / statistics & numerical data*
  • Mastectomy, Segmental / methods*
  • Middle Aged
  • Neoplasm Invasiveness
  • Prognosis
  • Sentinel Lymph Node Biopsy